STAT+: Fecal matter transplants could help certain cancer drugs work in more people, study shows 

Checkpoint inhibitors like Keytruda and Opdivo can be incredibly powerful cancer-killing drugs — when they work, that is, which is less than 70% of the time. For years, scientists have hoped to find a way to identify a combination of therapies that might help these drugs work for a larger number of people.
New clinical trial results published Thursday in Science provide some of the strongest evidence yet for an unusual but promising mashup: pairing immunotherapy drugs with fecal microbiota transplants, or FMTs. Continue to STAT+ to read the full story…